{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:53:52Z","timestamp":1793325232473,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/aps.2017.207","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T10:01:19Z","timestamp":1525946479000},"page":"1463-1472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Fluoxetine induces lipid metabolism abnormalities by acting on the liver in patients and mice with depression"],"prefix":"10.1038","volume":"39","author":[{"given":"Shu-juan","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-long","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-wu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"key":"140_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/7854_2012_211","volume":"14","author":"PA Zunszain","year":"2013","unstructured":"Zunszain PA, Hepgul N, Pariante CM. Inflammation and depression. Curr Top Behav Neurosci 2013; 14: 135\u201351.","journal-title":"Curr Top Behav Neurosci"},{"key":"140_CR2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jad.2010.10.001","volume":"129","author":"K DelMastro","year":"2011","unstructured":"DelMastro K, Hellem T, Kim N, Kondo D, Sung YH, Renshaw PF. Incidence of major depressive episode correlates with elevation of substate region of residence. J Affect Disord 2011; 129: 376\u20139.","journal-title":"J Affect Disord"},{"key":"140_CR3","first-page":"87","volume":"9","author":"P Sobocki","year":"2006","unstructured":"Sobocki P, Jonsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ 2006; 9: 87\u201398.","journal-title":"J Ment Health Policy Econ"},{"key":"140_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1345\/aph.19079","volume":"34","author":"GD Garrison","year":"2000","unstructured":"Garrison GD, Levin GM. Factors affecting prescribing of the newer antidepressants. Ann Pharmacother 2000; 34: 10\u20134.","journal-title":"Ann Pharmacother"},{"key":"140_CR5","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1194\/jlr.M037812","volume":"54","author":"F Nassir","year":"2013","unstructured":"Nassir F, Adewole OL, Brunt EM, Abumrad NA. CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob\/ob mice. J Lipid Res 2013; 54: 2988\u201397.","journal-title":"J Lipid Res"},{"key":"140_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1586\/erc.11.15","volume":"9","author":"J Richard","year":"2011","unstructured":"Richard J, Lingvay I. Hepatic steatosis and Type 2 diabetes: current and future treatment considerations. Expert Rev Cardiovasc Ther 2011; 9: 321\u20138.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"140_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1124\/jpet.117.240242","volume":"362","author":"TB Estridge","year":"2017","unstructured":"Estridge TB, Dey AB, Reidy C, Yu X, Zhang Y, Hartley M, et al. Identification of 4-aminopyrazolopyrimidine metabolite that may contribute to the hypolipidemic effects of LY2584702 in long evans diet-induced obese rats. J Pharmacol Exp Ther 2017; 362: 108\u201318.","journal-title":"J Pharmacol Exp Ther"},{"key":"140_CR8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/JCI0215593","volume":"109","author":"JD Horton","year":"2002","unstructured":"Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109: 1125\u201331.","journal-title":"J Clin Invest"},{"key":"140_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1530\/JOE-16-0142","volume":"230","author":"X Tang","year":"2016","unstructured":"Tang X, Li J, Xiang W, Cui Y, Xie B, Wang X, et al. Metformin increases hepatic leptin receptor and decreases steatosis in mice. J Endocrinol 2016; 230: 227\u201337.","journal-title":"J Endocrinol"},{"key":"140_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.tem.2011.03.003","volume":"22","author":"AD Quiroga","year":"2011","unstructured":"Quiroga AD, Lehner R. Role of endoplasmic reticulum neutral lipid hydrolases. Trends Endocrinol Metab 2011; 22: 218\u201325.","journal-title":"Trends Endocrinol Metab"},{"key":"140_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1042\/bj3380761","volume":"338","author":"R Lehner","year":"1999","unstructured":"Lehner R, Cui Z, Vance DE. Subcellullar localization, developmental expression and characterization of a liver triacylglycerol hydrolase. Biochem J 1999; 338: 761\u20138.","journal-title":"Biochem J"},{"key":"140_CR12","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.bbalip.2009.07.006","volume":"1791","author":"KW Ko","year":"2009","unstructured":"Ko KW, Erickson B, Lehner R. Es-x\/Ces1 prevents triacylglycerol accumulation in McArdle-RH7777 hepatocytes. Biochim Biophys Acta 2009; 1791: 1133\u201343.","journal-title":"Biochim Biophys Acta"},{"key":"140_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013; 70: 31\u201341.","journal-title":"JAMA Psychiatry"},{"key":"140_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.biocel.2014.07.019","volume":"54","author":"J Xiong","year":"2014","unstructured":"Xiong J, Yang H, Wu L, Shang W, Shan E, Liu W, et al. Fluoxetine suppresses AMP-activated protein kinase signaling pathway to promote hepatic lipid accumulation in primary mouse hepatocytes. Int J Biochem Cell Biol 2014; 54: 236\u201344.","journal-title":"Int J Biochem Cell Biol"},{"key":"140_CR15","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/cns.12014","volume":"18","author":"XM Feng","year":"2012","unstructured":"Feng XM, Xiong J, Qin H, Liu W, Chen RN, Shang W, et al. Fluoxetine induces hepatic lipid accumulation via both promotion of the SREBP1c-related lipogenesis and reduction of lipolysis in primary mouse hepatocytes. CNS Neurosci Ther 2012; 18: 974\u201380.","journal-title":"CNS Neurosci Ther"},{"key":"140_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bcp.2012.04.002","volume":"84","author":"D Xiao","year":"2012","unstructured":"Xiao D, Chen YT, Yang D, Yan B. Age-related inducibility of carboxylesterases by the antiepileptic agent phenobarbital and implications in drug metabolism and lipid accumulation. Biochem Pharmacol 2012; 84: 232\u20139.","journal-title":"Biochem Pharmacol"},{"key":"140_CR17","doi-asserted-by":"publisher","first-page":"pyw037","DOI":"10.1093\/ijnp\/pyw037","volume":"19","author":"RH Du","year":"2016","unstructured":"Du RH, Tan J, Sun XY, Lu M, Ding JH, Hu G. Fluoxetine inhibits NLRP3 inflammasome activation: implication in depression. Int J Neuropsychopharmacol 2016; 19: pyw037.","journal-title":"Int J Neuropsychopharmacol"},{"key":"140_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12264-017-0189-z","volume":"34","author":"K Li","year":"2017","unstructured":"Li K, Shen S, Ji YT, Li XY, Zhang LS, Wang XD. Melatonin augments the effects of fluoxetine on depression-like behavior and hippocampal BDNF-TrkB signaling. Neurosci Bull 2017; 34: 303\u201311.","journal-title":"Neurosci Bull"},{"key":"140_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12974-017-0985-4","volume":"14","author":"WJ Su","year":"2017","unstructured":"Su WJ, Peng W, Gong H, Liu YZ, Zhang Y, Lian YJ, et al. Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance. J Neuroinflammation 2017; 14: 210.","journal-title":"J Neuroinflammation"},{"key":"140_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jad.2017.02.034","volume":"214","author":"K Masuda","year":"2017","unstructured":"Masuda K, Nakanishi M, Okamoto K, Kawashima C, Oshita H, Inoue A, et al. Different functioning of prefrontal cortex predicts treatment response after a selective serotonin reuptake inhibitor treatment in patients with major depression. J Affect Disord 2017; 214: 44\u201352.","journal-title":"J Affect Disord"},{"key":"140_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/10401230209147454","volume":"14","author":"PS Masand","year":"2002","unstructured":"Masand PS, Gupta S. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine. Ann Clin Psychiatry 2002; 14: 175\u201382.","journal-title":"Ann Clin Psychiatry"},{"key":"140_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0149-2918(00)88317-4","volume":"21","author":"H Croft","year":"1999","unstructured":"Croft H, Settle E Jr, Houser T, Batey SR, Donahue RM, Ascher JA. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 1999; 21: 643\u201358.","journal-title":"Clin Ther"},{"key":"140_CR23","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nrd1821","volume":"4","author":"DT Wong","year":"2005","unstructured":"Wong DT, Perry KW, Bymaster FP. Case history: the discovery of fluoxetine hydrochloride (Prozac). Nat Rev Drug Discov 2005; 4: 764\u201374.","journal-title":"Nat Rev Drug Discov"},{"key":"140_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/YIC.0b013e328339fbbd","volume":"25","author":"AH Farabaugh","year":"2010","unstructured":"Farabaugh AH, Bitran S, Witte J, Alpert J, Chuzi S, Clain AJ, et al. Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome. Int Clin Psychopharmacol 2010; 25: 214\u20137.","journal-title":"Int Clin Psychopharmacol"},{"key":"140_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4088\/PCC.v05n0105","volume":"5","author":"CH Mallinckrodt","year":"2003","unstructured":"Mallinckrodt CH, Goldstein DJ, Detke MJ, Lu Y, Watkin JG, Tran PV. Duloxetine: A new treatment for the emotional and physical symptoms of depression. Prim Care Companion J Clin Psychiatry 2003; 5: 19\u201328.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"140_CR26","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.4088\/JCP.v67n1219","volume":"67","author":"MB Raeder","year":"2006","unstructured":"Raeder MB, Bjelland I, Emil Vollset S, Steen VM. Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study. J Clin Psychiatry 2006; 67: 1974\u201382.","journal-title":"J Clin Psychiatry"},{"key":"140_CR27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/JCP.0000000000000582","volume":"36","author":"KK Fjukstad","year":"2016","unstructured":"Fjukstad KK, Engum A, Lydersen S, Dieset I, Steen NE, Andreassen OA, et al. Metabolic abnormalities related to treatment with selective serotonin reuptake inhibitors in patients with schizophrenia or bipolar disorder. J Clin Psychopharmacol 2016; 36: 615\u201320.","journal-title":"J Clin Psychopharmacol"},{"key":"140_CR28","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1177\/0269881108094320","volume":"23","author":"JM Le Melledo","year":"2009","unstructured":"Le Melledo JM, Mailo K, Lara N, Abadia MC, Gil L, Van Ameringen M, et al. Paroxetine-induced increase in LDL cholesterol levels. J Psychopharmacol 2009; 23: 826\u201330.","journal-title":"J Psychopharmacol"},{"key":"140_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/archpsyc.62.2.190","volume":"62","author":"MR Liebowitz","year":"2005","unstructured":"Liebowitz MR, Gelenberg AJ, Munjack D. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Arch Gen Psychiatry 2005; 62: 190\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"140_CR30","doi-asserted-by":"crossref","unstructured":"Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB. et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004; 44: 720\u201332.","DOI":"10.1016\/j.jacc.2004.07.001"},{"key":"140_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/j.1550-8528.1996.tb00268.x","volume":"4","author":"F Pedrinola","year":"1996","unstructured":"Pedrinola F, Sztejnsznajd C, Lima N, Halpern A, Medeiros-Neto G. The addition of dexfenfluramine to fluoxetine in the treatment of obesity: a randomized clinical trial. Obes Res 1996; 4: 549\u201354.","journal-title":"Obes Res"},{"key":"140_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/j.1550-8528.1994.tb00641.x","volume":"2","author":"M Visser","year":"1994","unstructured":"Visser M, Seidell JC, Koppeschaar HP, Smits P. No specific effect of fluoxetine treatment on fasting glucose, insulin, lipid levels, and blood pressure in healthy men with abdominal obesity. Obes Res 1994; 2: 152\u20139.","journal-title":"Obes Res"},{"key":"140_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1464-5491.1994.tb00238.x","volume":"11","author":"M O'Kane","year":"1994","unstructured":"O'Kane M, Wiles PG, Wales JK. Fluoxetine in the treatment of obese type 2 diabetic patients. Diabet Med 1994; 11: 105\u201310.","journal-title":"Diabet Med"},{"key":"140_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2008-2231-21-4","volume":"21","author":"E Shahsavand Ananloo","year":"2013","unstructured":"Shahsavand Ananloo E, Ghaeli P, Kamkar MZ, Sadeghi M. Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression. Daru 2013; 21: 4.","journal-title":"Daru"},{"key":"140_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5152\/npa.2016.12373","volume":"54","author":"O Olguner Eker","year":"2017","unstructured":"Olguner Eker O, Ozsoy S, Eker B, Dogan H. Metabolic effects of antidepressant treatment. Noro Psikiyatr Ars 2017; 54: 49\u201356.","journal-title":"Noro Psikiyatr Ars"},{"key":"140_CR36","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1007\/s00213-016-4361-3","volume":"233","author":"LK Kuehl","year":"2016","unstructured":"Kuehl LK, Muhtz C, Hinkelmann K, Dettenborn L, Wingenfeld K, Spitzer C, et al. Association between major depression and cardiovascular risk: the role of antidepressant medication. Psychopharmacology (Berl) 2016; 233: 3289\u201395.","journal-title":"Psychopharmacology (Berl)"},{"key":"140_CR37","first-page":"1525","volume":"16","author":"M Kesim","year":"2011","unstructured":"Kesim M, Tiryaki A, Kadioglu M, Muci E, Kalyoncu NI, Yaris E. The effects of sertraline on blood lipids, glucose, insulin and HBA1C levels: A prospective clinical trial on depressive patients. J Res Med Sci 2011; 16: 1525\u201331.","journal-title":"J Res Med Sci"},{"key":"140_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00213-007-0833-9","volume":"194","author":"MJ Fell","year":"2007","unstructured":"Fell MJ, Anjum N, Dickinson K, Marshall KM, Peltola LM, Vickers S, et al. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats. Psychopharmacology (Berl) 2007; 194: 221\u201331.","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2017207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2017207","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/aps.2017.207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/aps2017207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:36:17Z","timestamp":1684413377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2017207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["140"],"URL":"https:\/\/doi.org\/10.1038\/aps.2017.207","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,10]]},"assertion":[{"value":"27 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}